rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

First Tracks Biotherapeutics, Inc. -

TRAX · Nasdaq

Health CareBiotechnology

We hold no 150-day reading for TRAX yet: it needs about 200 sessions of history. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
not in the set
Weeks in an uptrend
—
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$133.5M
Officials’ trades on record
0
Institutions holding
144

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$125.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 2
WhoDidSharesTraded
J. Anthony WareDirectorsold39,265at $44.782 Sep 2026filed 4 Sep 2026
Ecor1 Capital, Llc10% ownersold4,705,575at $13.8120 Apr 2026filed 22 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders144
New · exited144 · 0
Reported value$659.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
EcoR1 Capital, LLCnew · filed 14 Aug 20263,174,519$63.9M+3,174,519
TCG Crossover Management, LLCnew · filed 14 Aug 20262,895,304$58.3M+2,895,304
FMR LLCnew · filed 13 Aug 20262,054,127$41.3M+2,054,127
Affinity Asset Advisors, LLCnew · filed 13 Aug 20262,032,012$40.9M+2,032,012
BlackRock, Inc.new · filed 7 Aug 20261,963,541$39.5M+1,963,541
Trails Edge Capital Partners, LPnew · filed 14 Aug 20261,514,000$30.5M+1,514,000
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 20261,451,909$29.2M+1,451,909
Jupiter Topco LLCnew · filed 14 Aug 20261,091,464$22.0M+1,091,464
Vestal Point Capital, LPnew · filed 14 Aug 20261,013,000$20.4M+1,013,000
Woodline Partners LPnew · filed 14 Aug 2026917,176$18.5M+917,176

Everyone who traded it

John A. Orwin Company insiderDirector · last 15 Sep 20260 · 0
J. Anthony Ware Company insiderDirector · last 2 Sep 20260 · 1
Benjamin Stone Company insiderChief Business Officer · last 15 Aug 20260 · 0
Daniel Faga Company insiderPresident, CEO · last 15 Aug 20260 · 0
Paul F. Lizzul Company insiderChief Medical Officer · last 15 Aug 20260 · 0
Dennis M. Fenton Company insiderDirector · last 15 Jun 20260 · 0
John P. Schmid Company insiderDirector · last 15 Jun 20260 · 0
Magda Marquet Company insiderDirector · last 15 Jun 20260 · 0
Rita Jain Company insiderDirector · last 15 Jun 20260 · 0
Ajim Tamboli Company insiderChief Financial Officer · last 12 May 20260 · 0
ANAPTYSBIO, INC Company insider10% owner · last 20 Apr 20260 · 0
EcoR1 Capital, LLC Company insider10% owner · last 20 Apr 20260 · 1

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.